Literature DB >> 20064431

Telomeres and telomerase: from discovery to clinical trials.

David R Corey1.   

Abstract

Telomeres are the ends of linear chromosomes. They cannot be fully replicated by standard polymerases and are maintained by the ribonucleoprotein telomerase. Telomeres and telomerase stand at a junction of critical processes underlying chromosome integrity, cancer, and aging, and their importance was recognized by the 2009 Nobel Prize in Physiology or Medicine to Elizabeth Blackburn, Jack Szostak, and Carol Greider. Where will the field go now? What are the prospects for antitelomerase agents as drugs? Nearly 30 years after Szostak and Blackburn's pioneering manuscript on telomere ends, the challenges of discovery remain. Copyright 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20064431      PMCID: PMC2810624          DOI: 10.1016/j.chembiol.2009.12.001

Source DB:  PubMed          Journal:  Chem Biol        ISSN: 1074-5521


  51 in total

Review 1.  Structures of telomerase subunits provide functional insights.

Authors:  Vijay G Sekaran; Joana Soares; Michael B Jarstfer
Journal:  Biochim Biophys Acta       Date:  2009-08-07

2.  Origin of concatemeric T7 DNA.

Authors:  J D Watson
Journal:  Nat New Biol       Date:  1972-10-18

3.  A tandemly repeated sequence at the termini of the extrachromosomal ribosomal RNA genes in Tetrahymena.

Authors:  E H Blackburn; J G Gall
Journal:  J Mol Biol       Date:  1978-03-25       Impact factor: 5.469

4.  Telomeres shorten during ageing of human fibroblasts.

Authors:  C B Harley; A B Futcher; C W Greider
Journal:  Nature       Date:  1990-05-31       Impact factor: 49.962

5.  Correlating telomerase activity levels with human neuroblastoma outcomes.

Authors:  E Hiyama; K Hiyama; T Yokoyama; Y Matsuura; M A Piatyszek; J W Shay
Journal:  Nat Med       Date:  1995-03       Impact factor: 53.440

Review 6.  Telomeres and aging.

Authors:  Geraldine Aubert; Peter M Lansdorp
Journal:  Physiol Rev       Date:  2008-04       Impact factor: 37.312

7.  Structure of the Tribolium castaneum telomerase catalytic subunit TERT.

Authors:  Andrew J Gillis; Anthony P Schuller; Emmanuel Skordalakes
Journal:  Nature       Date:  2008-08-31       Impact factor: 49.962

8.  Consequences of telomerase inhibition and combination treatments for the proliferation of cancer cells.

Authors:  Zhi Chen; Kenneth S Koeneman; David R Corey
Journal:  Cancer Res       Date:  2003-09-15       Impact factor: 12.701

Review 9.  Telomerase and cancer therapeutics.

Authors:  Calvin B Harley
Journal:  Nat Rev Cancer       Date:  2008-03       Impact factor: 60.716

10.  An RNA-dependent RNA polymerase formed by TERT and the RMRP RNA.

Authors:  Yoshiko Maida; Mami Yasukawa; Miho Furuuchi; Timo Lassmann; Richard Possemato; Naoko Okamoto; Vivi Kasim; Yoshihide Hayashizaki; William C Hahn; Kenkichi Masutomi
Journal:  Nature       Date:  2009-08-23       Impact factor: 49.962

View more
  13 in total

1.  Old age as a privilege of the "selfish ones".

Authors:  Mladen Davidovic; Goran Sevo; Petar Svorcan; Dragoslav P Milosevic; Nebojsa Despotovic; Predrag Erceg
Journal:  Aging Dis       Date:  2010-07-30       Impact factor: 6.745

2.  Catalysis-dependent inactivation of human telomerase and its reactivation by intracellular telomerase-activating factors (iTAFs).

Authors:  Mohammed E Sayed; Ao Cheng; Gaya P Yadav; Andrew T Ludlow; Jerry W Shay; Woodring E Wright; Qiu-Xing Jiang
Journal:  J Biol Chem       Date:  2019-06-11       Impact factor: 5.157

Review 3.  In perspective: An update on telomere targeting in cancer.

Authors:  Eric T Sugarman; Gao Zhang; Jerry W Shay
Journal:  Mol Carcinog       Date:  2019-05-06       Impact factor: 4.784

4.  Binding of gemini bisbenzimidazole drugs with human telomeric G-quadruplex dimers: effect of the spacer in the design of potent telomerase inhibitors.

Authors:  Ananya Paul; Akash K Jain; Santosh K Misra; Basudeb Maji; K Muniyappa; Santanu Bhattacharya
Journal:  PLoS One       Date:  2012-06-21       Impact factor: 3.240

5.  An improved model for the hTERT promoter quadruplex.

Authors:  Jonathan B Chaires; John O Trent; Robert D Gray; William L Dean; Robert Buscaglia; Shelia D Thomas; Donald M Miller
Journal:  PLoS One       Date:  2014-12-19       Impact factor: 3.240

Review 6.  Aptamer Bioinformatics.

Authors:  Andrew B Kinghorn; Lewis A Fraser; Shaolin Lang; Simon Chi-Chin Shiu; Julian A Tanner
Journal:  Int J Mol Sci       Date:  2017-11-24       Impact factor: 5.923

7.  Ethenesulfonyl fluoride derivatives as telomerase inhibitors: structure-based design, SAR, and anticancer evaluation in vitro.

Authors:  Xing Chen; Gao-Feng Zha; Jie Quan Wang; Xin-Hua Liu
Journal:  J Enzyme Inhib Med Chem       Date:  2018-12       Impact factor: 5.051

Review 8.  The intervention on aging system: A classification model, the requirement for five novel categories.

Authors:  Raymond D Palmer
Journal:  Aging Med (Milton)       Date:  2022-01-30

9.  Epstein-Barr virus and telomerase: from cell immortalization to therapy.

Authors:  Riccardo Dolcetti; Silvia Giunco; Jessica Dal Col; Andrea Celeghin; Katy Mastorci; Anita De Rossi
Journal:  Infect Agent Cancer       Date:  2014-02-26       Impact factor: 2.965

Review 10.  Chemistry, mechanism and clinical status of antisense oligonucleotides and duplex RNAs.

Authors:  Xiulong Shen; David R Corey
Journal:  Nucleic Acids Res       Date:  2018-02-28       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.